Agios Pharmaceuticals Inc (NASDAQ: AGIO) is 111.76% higher on its value in year-to-date trading and has touched a low of $19.80 and a high of $49.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AGIO stock was last observed hovering at around $48.05 in the last trading session, with the day’s loss setting it -0.89%.
Currently trading at $47.16, the stock is 7.72% and 16.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.91 million and changing -1.85% at the moment leaves the stock 61.20% off its SMA200. AGIO registered 73.64% gain for a year compared to 6-month gain of 114.95%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 6.91% loss in the last 1 month and extending the period to 3 months gives it a 63.75%, and is 8.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.83% over the week and 3.95% over the month.
Agios Pharmaceuticals Inc (AGIO) has around 383 employees, a market worth around $2.68B and $29.40M in sales. Profit margin for the company is -1199.26%. Distance from 52-week low is 138.24% and -3.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.25%).
The EPS is expected to grow by 69.44% this year
The shares outstanding are 55.95M, and float is at 55.38M with Short Float at 5.65%.
Agios Pharmaceuticals Inc (AGIO) Insider Activity
The most recent transaction is an insider sale by Gheuens Sarah, the company’s Chief Medical Officer. SEC filings show that Gheuens Sarah sold 3,705 shares of the company’s common stock on Jul 01 ’24 at a price of $43.85 per share for a total of $0.16 million. Following the sale, the insider now owns 43736.0 shares.
Agios Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 05 ’24 that Goff Brian (Chief Executive Officer) sold a total of 12,115 shares of the company’s common stock. The trade occurred on Jun 05 ’24 and was made at $48.84 per share for $0.59 million. Following the transaction, the insider now directly holds 67192.0 shares of the AGIO stock.
Still, SEC filings show that on Jun 03 ’24, Washburn Theodore James Jr. (Principal Accounting Officer) disposed off 1,362 shares at an average price of $44.39 for $60459.0. The insider now directly holds 1,524 shares of Agios Pharmaceuticals Inc (AGIO).
